NRC Health NRC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 38.40M | 35.39M | 34.80M | 35.19M | 34.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.40M | 35.39M | 34.80M | 35.19M | 34.61M |
| Cost of Revenue | 15.38M | 13.56M | 13.65M | 13.94M | 12.40M |
| Gross Profit | 23.02M | 21.83M | 21.16M | 21.26M | 22.20M |
| SG&A Expenses | 12.05M | 19.79M | 13.42M | 7.79M | 12.27M |
| Depreciation & Amortization | 2.07M | 2.12M | 2.17M | 2.15M | 2.20M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.49M | 35.47M | 29.23M | 23.87M | 26.87M |
| Operating Income | 8.91M | -78.00K | 5.57M | 11.32M | 7.74M |
| Income Before Tax | 7.40M | -4.54M | 4.38M | 3.27M | 6.27M |
| Income Tax Expenses | 2.70M | -1.25M | 1.16M | 1.47M | 2.15M |
| Earnings from Continuing Operations | 4.70M | -3.28M | 3.22M | 1.80M | 4.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.70M | -3.28M | 3.22M | 1.80M | 4.12M |
| EBIT | 8.91M | -78.00K | 5.57M | 11.32M | 7.74M |
| EBITDA | 10.98M | 2.04M | 7.74M | 13.47M | 9.93M |
| EPS Basic | 0.22 | -0.15 | 0.14 | 0.08 | 0.18 |
| Normalized Basic EPS | 0.21 | -0.04 | 0.13 | 0.28 | 0.18 |
| EPS Diluted | 0.21 | -0.15 | 0.14 | 0.07 | 0.18 |
| Normalized Diluted EPS | 0.21 | -0.04 | 0.12 | 0.28 | 0.18 |
| Average Basic Shares Outstanding | 21.72M | 22.01M | 21.80M | 21.79M | 22.13M |
| Average Diluted Shares Outstanding | 21.89M | 22.01M | 21.91M | 21.81M | 22.13M |
| Dividend Per Share | 0.16 | 0.16 | 0.16 | 0.16 | 0.12 |
| Payout Ratio | 75.32% | -109.84% | 112.51% | 150.06% | 67.35% |